IPO registrations (S-1, F-1) · Registrants
GENTA INC DE/
- SEC CIK
- 880643 · filings on EDGAR ↗
- Former names
- GENTA INCORPORATED /DE/ (1996–2002)
- Registration
- Form S-1, first filed 2003-11-04, last 2009-12-21; 3 initial registrations, 7 amendments
- Outcome
- Declared effective 2009-12-23; withdrawal requested 2010-09-24
- Industry (SIC)
- Biological Products, (No Diagnostic Substances) 2836
- Incorporated in
- DE
- Business address
- 200 CONNELL DRIVE, .., Berkeley Heights, NJ 07922
- EIN
- 33-0326866
- EDGAR entity type
- operating
- Insiders and CEO pay
- GENTA INC DE/ on the corporate pages
Offering terms
- Shares offered
- 54,713,329
- Listing
- OTC under the symbol GETA.OB
Read from the cover pages of the filings listed under “Prospectus pages read” below; check the document for anything that matters.
On this site
- Form 5500 plan sponsor: GENTA INCORPORATED EXACT (EIN (EXACT))
- SEC filer: GENTA INC DE/ EXACT (CIK (EXACT))
- Person page: Douglas G Watson Fuzzy (officer, director or 10% owner on the company's Forms 3, 4 and 5 (Director))
Filings 13
| Filed | Form | What it is | Name as filed | EDGAR |
|---|---|---|---|---|
| 2003-11-04 | S-1 | S-1 (registration) | GENTA INC DE/ | 0000950103-03-002126 ↗ |
| 2003-12-08 | S-1/A | S-1/A (amendment) | GENTA INC DE/ | 0000950103-03-002290 ↗ |
| 2008-08-29 | S-1 | S-1 (registration) | GENTA INC DE/ | 0000950123-08-010461 ↗ |
| 2009-03-09 | S-1/A | S-1/A (amendment) | GENTA INC DE/ | 0000950123-09-004228 ↗ |
| 2009-05-29 | S-1/A | S-1/A (amendment) | GENTA INC DE/ | 0001144204-09-030171 ↗ |
| 2009-06-17 | S-1/A | S-1/A (amendment) | GENTA INC DE/ | 0001144204-09-033115 ↗ |
| 2009-07-30 | S-1/A | S-1/A (amendment) | GENTA INC DE/ | 0001144204-09-039362 ↗ |
| 2009-08-14 | S-1/A | S-1/A (amendment) | GENTA INC DE/ | 0001144204-09-043823 ↗ |
| 2009-09-24 | S-1 | S-1 (registration) | GENTA INC DE/ | 0001144204-09-049829 ↗ |
| 2009-12-21 | S-1/A | S-1/A (amendment) | GENTA INC DE/ | 0001144204-09-065684 ↗ |
| 2009-12-23 | EFFECT | EFFECT (declared effective) | GENTA INC DE/ | 9999999995-09-003595 ↗ |
| 2010-01-12 | EFFECT | EFFECT (declared effective) | GENTA INC DE/ | 9999999995-10-000198 ↗ |
| 2010-09-24 | RW | RW (withdrawal request) | GENTA INC DE/ | 0001437749-10-003108 ↗ |
Prospectus pages read 1
| Filed | Form | Read as | Range | Price | Shares | Proceeds | Listing | Underwriters | What was found | Document |
|---|---|---|---|---|---|---|---|---|---|---|
| 2009-12-21 | S-1/A | registration statement | 54,713,329 | - | OTC GETA.OB | 0 | primary document; shares headline | document ↗ |
Officers, directors and large holders Forms 3, 4 and 5
| Insider | Role | Title | Filings | Years | On this site |
|---|---|---|---|---|---|
| Sanders Walter Lloyd | Officer | Chief Operating Officer; Senior VP, Chief Operating Off; Senior VP & COO; Sr VP, Commercial Operations; VP, Sales & Marketing | 8 | 2006–2009 | |
| ITRI LORETTTA M | Officer | Pres. & CMO; Pres and Chief Medical Officer; Pres. & Chief Medical Officer; Pres & CMO; Pres. & CMO; President, Pharmaceutical Dev; President Pharm. Dev. and CMO; President, Pharm. Dev. CMO; Pres. Pharm Devel & CMO; Pres R&D Chief Medical Officer; Pres RD Chief Medical Officer | 38 | 2006–2012 | |
| Moran Richard J | Officer | Senior VP, CFO and Corp. Sec.; Sr. VP Cheif Financial Officer; Sr. VP Chief Financial Officer | 4 | 2006–2007 | |
| WARRELL RAYMOND P JR | Director,Officer | Chairman & CEO; Chairman and CEO; Chairman & CEO; Chairman & Chief Exec Officer; Chairman & Chief Exec. Officer | 37 | 2006–2012 | |
| Driscoll Martin J | Director | 5 | 2006–2008 | ||
| GROOPMAN JEROME | Director; Other | 2 | 2006 | ||
| VON HOFF DANIEL | Director | 9 | 2006–2010 | ||
| WATSON DOUGLAS G | Director | 9 | 2006–2010 | person page Fuzzy | |
| MCCAUGHEY BETSY | Director | 2 | 2006–2007 | ||
| Parios Christopher P | Director | 7 | 2006–2010 | ||
| SIEGEL GARY | Officer | Vice President, Finance | 6 | 2008–2012 |
Everyone who filed an insider report for this company, from the SEC’s Insider Transactions Data Sets (2006 on). Person pages are matched by name and state only.
Data: SEC EDGAR. The quarterly full index (every S-1, S-1/A, F-1 and F-1/A since 1993, with the pricing prospectus, notice of effectiveness and withdrawal request of each registrant) and the company submissions data (SIC, state of incorporation, address, EIN, tickers, former names). Company details are what EDGAR holds today, not at the time of the filing.
Also on this site Fuzzy
| Record | Name as filed | Where | Dataset | Matched by |
|---|---|---|---|---|
| SEC filer | GENTA INC DE/ | SEC filers (EDGAR) | CIK (EXACT) | |
| Form 5500 plan sponsor | GENTA INCORPORATED | EIN (EXACT) | ||
| Person page | Douglas G Watson | People (Form 990 officers, directors and employees) | officer, director or 10% owner on the company's Forms 3, 4 and 5 (Director) |
Matched by an identifier (EIN, CIK, CRD), by name and state or city, or by street address; a shared name or address is not proof of the same person or organization. Every link says how it was made; how the cross-referencing works.
Others with the same interests
SIC industry Biological Products, (No Diagnostic Substances), NJ first:
- IGX CORP/DE NJ
- ADMA BIOLOGICS, INC. NJ
- Point of Care Nano-Technology, Inc. NJ
- Outlook Therapeutics, Inc. NJ
- Oyster Point Pharma, Inc. NJ
- Kalaris Therapeutics, Inc. NJ
- Tevogen Inc. NJ
- TAMIR BIOTECHNOLOGY, INC. NJ
- BioNTech SE 2M
- Immatics N.V. 2M
In other datasets, the same topic (Health) in NJ:
- Nonprofit: 1ST CEREBRAL PALSY OF NEW JERSEY INC (Nonprofits (IRS Form 990))
Interests: Biological Products, (No Diagnostic Substances) · Health